Michiya Yokozaki

769 total citations
37 papers, 517 citations indexed

About

Michiya Yokozaki is a scholar working on Pulmonary and Respiratory Medicine, Infectious Diseases and Surgery. According to data from OpenAlex, Michiya Yokozaki has authored 37 papers receiving a total of 517 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 8 papers in Infectious Diseases and 8 papers in Surgery. Recurrent topics in Michiya Yokozaki's work include Antibiotic Resistance in Bacteria (8 papers), Bacterial Identification and Susceptibility Testing (5 papers) and Lung Cancer Treatments and Mutations (4 papers). Michiya Yokozaki is often cited by papers focused on Antibiotic Resistance in Bacteria (8 papers), Bacterial Identification and Susceptibility Testing (5 papers) and Lung Cancer Treatments and Mutations (4 papers). Michiya Yokozaki collaborates with scholars based in Japan, Burkina Faso and France. Michiya Yokozaki's co-authors include Tomoyuki Yokose, Yutaka Nishiwaki, Tetsuro Kodama, Hiroki Ohge, Norifumi Shigemoto, Ikuo Sekine, Makoto Onodera, Motoyuki Sugai, Junji Yoshida and Shizuo Kayama and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer.

In The Last Decade

Michiya Yokozaki

36 papers receiving 502 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michiya Yokozaki Japan 14 152 118 118 114 113 37 517
Xiuyu Song China 10 55 0.4× 70 0.6× 54 0.5× 41 0.4× 151 1.3× 30 395
Jin‐Tae Suh South Korea 10 48 0.3× 86 0.7× 114 1.0× 73 0.6× 89 0.8× 31 394
Mariona Calvo Spain 7 52 0.3× 179 1.5× 77 0.7× 34 0.3× 74 0.7× 20 344
Minori Matsumoto Japan 12 178 1.2× 189 1.6× 94 0.8× 103 0.9× 86 0.8× 36 446
Spartaco Sani Italy 7 337 2.2× 461 3.9× 84 0.7× 34 0.3× 104 0.9× 12 875
James M. Kidd United States 18 149 1.0× 24 0.2× 137 1.2× 57 0.5× 227 2.0× 31 658
Magdalena Chrapek Poland 13 29 0.2× 70 0.6× 69 0.6× 54 0.5× 124 1.1× 59 501
Michael L. Neugent United States 11 88 0.6× 26 0.2× 324 2.7× 93 0.8× 209 1.8× 22 604
B U Ridwan Netherlands 10 93 0.6× 32 0.3× 133 1.1× 173 1.5× 71 0.6× 12 518
V. Rodríguez United States 11 88 0.6× 162 1.4× 76 0.6× 42 0.4× 59 0.5× 32 468

Countries citing papers authored by Michiya Yokozaki

Since Specialization
Citations

This map shows the geographic impact of Michiya Yokozaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michiya Yokozaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michiya Yokozaki more than expected).

Fields of papers citing papers by Michiya Yokozaki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michiya Yokozaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michiya Yokozaki. The network helps show where Michiya Yokozaki may publish in the future.

Co-authorship network of co-authors of Michiya Yokozaki

This figure shows the co-authorship network connecting the top 25 collaborators of Michiya Yokozaki. A scholar is included among the top collaborators of Michiya Yokozaki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michiya Yokozaki. Michiya Yokozaki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hisatsune, Junzo, Takaya Segawa, Yo Sugawara, et al.. (2023). Complete genome sequence of cfr(B)-carrying Enterococcus raffinosus isolated from bile in a patient in Japan. Journal of Global Antimicrobial Resistance. 34. 43–45. 2 indexed citations
2.
Kitagawa, Hiroki, Hiroyuki Kitano, Toshinori Hara, et al.. (2023). Prevalence of Mycoplasma hominis, Ureaplasma urealyticum, and Ureaplasma parvum detection in urine and respiratory tract samples in Hiroshima, Japan. Heliyon. 9(3). e14543–e14543. 9 indexed citations
3.
Kitagawa, Hiroki, Hiroyuki Kitano, Toshinori Hara, et al.. (2022). Clinical characteristics of Actinotignum schaalii bacteremia in a Japanese tertiary hospital. Anaerobe. 77. 102513–102513. 5 indexed citations
4.
Masumoto, Norio, Michiya Yokozaki, Shinsuke Sasada, et al.. (2022). The tumor-infiltrating lymphocyte ultrasonography score can provide a diagnostic prediction of lymphocyte-predominant breast cancer preoperatively. Journal of Medical Ultrasonics. 49(4). 709–717. 3 indexed citations
5.
Sugiyama, Aya, Shintaro Nagashima, Serge Ouoba, et al.. (2022). Seroepidemiological study of factors affecting anti-spike IgG antibody titers after a two-dose mRNA COVID-19 vaccination in 3744 healthy Japanese volunteers. Scientific Reports. 12(1). 16294–16294. 11 indexed citations
6.
Masumoto, Norio, Michiya Yokozaki, Shinsuke Sasada, et al.. (2021). Ultrasonography Combined With Contrast-enhanced Ultrasonography Can Predict Lymphocyte-predominant Breast Cancer. Cancer Diagnosis & Prognosis. 1(4). 309–316. 3 indexed citations
7.
Kitagawa, Hiroki, Toshinori Hara, Seiya Kashiyama, et al.. (2021). Clinical and microbiological characteristics of Eggerthella lenta bacteremia at a Japanese tertiary hospital. Journal of Infection and Chemotherapy. 27(8). 1261–1264. 7 indexed citations
8.
Yamamoto, Hideya, Eiji Sugiyama, Masahiro Serikawa, et al.. (2017). Clinical features and predictive value of serum inflammatory markers of perivascular involvement in immunoglobulin G4-related disease. Heart and Vessels. 32(10). 1176–1185. 6 indexed citations
9.
Kayama, Shizuo, Norifumi Shigemoto, Makoto Onodera, et al.. (2011). Rapid detection of blaIMP-6 by amplification refractory mutation system. Journal of Microbiological Methods. 88(1). 182–184. 5 indexed citations
10.
Shigemoto, Norifumi, Shizuo Kayama, Makoto Onodera, et al.. (2011). Emergence in Japan of an imipenem-susceptible, meropenem-resistant Klebsiella pneumoniae carrying blaIMP-6. Diagnostic Microbiology and Infectious Disease. 72(1). 109–112. 39 indexed citations
11.
Oguri, Tetsuya, Yasuhiro Fujiwara, Osamu Katoh, et al.. (2000). Glutathione S-transferase-π gene expression and platinum drug exposure in human lung cancer. Cancer Letters. 156(1). 93–99. 23 indexed citations
12.
Ishioka, Shinichi, Keiko Hiyama, Takashi Nishisaka, et al.. (2000). An Autopsy Case of Diffuse Panbronchiolitis Associated with Lung Cancer.. Internal Medicine. 39(5). 404–406. 2 indexed citations
13.
Oguri, Tetsuya, Yasuhiro Fujiwara, Masahiro Ochiai, et al.. (1999). Expression of lung-resistance protein gene is not associated with platinum drug exposure in lung cancer.. PubMed. 18(6A). 4159–62. 8 indexed citations
14.
Oguri, Tetsuya, Yasuhiro Fujiwara, Masahito Miyazaki, et al.. (1999). Induction of λ-glutamylcysteine synthetase gene expression by platinum drugs in peripheral mononuclear cells of lung cancer patients. Annals of Oncology. 10(4). 455–460. 13 indexed citations
15.
Ogura, T., et al.. (1997). Association between p53 Mutation and Clinicopathological Features of Non-small Cell Lung Cancer. Japanese Journal of Clinical Oncology. 27(4). 211–215. 10 indexed citations
16.
Kubota, Kaoru, Yutaka Nishiwaki, Ryutaro Kakinuma, et al.. (1997). Dose-intensive weekly chemotherapy for treatment of relapsed small-cell lung cancer.. Journal of Clinical Oncology. 15(1). 292–296. 34 indexed citations
17.
Sekine, Ikuo, Yutaka Nishiwaki, Ryutaro Kakinuma, et al.. (1997). Phase II study of high-dose dexamethasone-based association in acute and delayed high-dose cisplatin-induced emesis – JCOG study 9413. British Journal of Cancer. 76(1). 90–92. 24 indexed citations
18.
Sekine, Ikuo, Yutaka Nishiwaki, Ryutaro Kakinuma, et al.. (1996). Late Recurrence of Small-Cell Lung Cancer: Treatment and Outcome. Oncology. 53(4). 318–321. 11 indexed citations
19.
Yokozaki, Michiya, et al.. (1996). Endobronchial Lipoma: A Report of Three Cases. Japanese Journal of Clinical Oncology. 26(1). 53–57. 15 indexed citations
20.
Sekine, Ikuo, Yutaka Nishiwaki, Kaoru Kubota, et al.. (1996). A Randomized Cross-over Trial of Granisetron and Dexamethasone versus Granisetron Alone: The Role of Dexamethasone on Day 1 in the Control of Cisplatin-induced Delayed Emesis. Japanese Journal of Clinical Oncology. 26(3). 164–168. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiuyu Song Breakdown of academic impact, for papers by Jin‐Tae Suh Breakdown of academic impact, for papers by Mariona Calvo Breakdown of academic impact, for papers by Minori Matsumoto Breakdown of academic impact, for papers by Spartaco Sani Breakdown of academic impact, for papers by James M. Kidd Breakdown of academic impact, for papers by Magdalena Chrapek Breakdown of academic impact, for papers by Michael L. Neugent Breakdown of academic impact, for papers by B U Ridwan Breakdown of academic impact, for papers by V. Rodríguez
Rankless by CCL
2026